| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.1377 | 42 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.817 | 48 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.4079 | 50 |
| GSM780719 | Untreated after 4 days (C1_2) | 57.1186 | 62 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.7165 | 26 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.5443 | 47 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.4246 | 19 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 57.9933 | 63 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 55.7968 | 61 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.9453 | 27 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.0733 | 56 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 61.346 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.6879 | 53 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.1716 | 49 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 52.7126 | 56 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 56.5297 | 61 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 62.8571 | 66 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 54.7635 | 59 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.0094 | 37 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.7347 | 44 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 55.2736 | 60 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.7181 | 48 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.432 | 50 |